» Articles » PMID: 30546093

REASSURED Diagnostics to Inform Disease Control Strategies, Strengthen Health Systems and Improve Patient Outcomes

Overview
Journal Nat Microbiol
Date 2018 Dec 15
PMID 30546093
Citations 263
Authors
Affiliations
Soon will be listed here.
Abstract

Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes.

Citing Articles

Recent Advances in Biosensor Technologies for Meat Production Chain.

Nastasijevic I, Kundacina I, Jaric S, Pavlovic Z, Radovic M, Radonic V Foods. 2025; 14(5).

PMID: 40077447 PMC: 11899517. DOI: 10.3390/foods14050744.


Development and Validation of a Combined RT-LAMP Assay for the Rapid and Sensitive Detection of Dengue Virus in Clinical Samples from Colombia.

Hurtado-Gomez L, Escorcia-Lindo K, Rosero J, Solano Llanos N, Barrios Sanchez C, Diaz Perez A Diagnostics (Basel). 2025; 15(5).

PMID: 40075817 PMC: 11898505. DOI: 10.3390/diagnostics15050570.


Rapid diagnosis of urinary tract infection with miniaturised point-of-care cultivation on a dipstick.

Iseri E, Jakobsson G, Bertling S, Ozenci V, Ekelund O, van der Wijngaart W Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 40063324 DOI: 10.1007/s10096-025-05088-7.


Enhanced and Sexually Transmitted Infections and Associated Risk Factors in Fiji Following the Coronavirus Disease 2019 Pandemic.

Auchus I, Brown J, Kama M, Vargo S, Devi R, Singh J Open Forum Infect Dis. 2025; 12(3):ofaf101.

PMID: 40046883 PMC: 11881064. DOI: 10.1093/ofid/ofaf101.


Cell-free DNA as a complementary diagnostic tool for neglected tropical diseases towards achieving the WHO NTDs elimination by 2030.

Osei-Poku P, Tritten L, Fordjour F, Kwarteng A J Liq Biopsy. 2025; 7:100283.

PMID: 40027229 PMC: 11863940. DOI: 10.1016/j.jlb.2024.100283.


References
1.
Nery E, Kubota L . Sensing approaches on paper-based devices: a review. Anal Bioanal Chem. 2013; 405(24):7573-95. DOI: 10.1007/s00216-013-6911-4. View

2.
Marks M, Yin Y, Chen X, Castro A, Causer L, Guy R . Metaanalysis of the Performance of a Combined Treponemal and Nontreponemal Rapid Diagnostic Test for Syphilis and Yaws. Clin Infect Dis. 2016; 63(5):627-633. PMC: 4981758. DOI: 10.1093/cid/ciw348. View

3.
Denkinger C, Grenier J, Stratis A, Akkihal A, Pant-Pai N, Pai M . Mobile health to improve tuberculosis care and control: a call worth making. Int J Tuberc Lung Dis. 2013; 17(6):719-27. DOI: 10.5588/ijtld.12.0638. View

4.
Boeras D, Peeling R . External quality assurance for HIV point-of-care testing in Africa: A collaborative country-partner approach to strengthen diagnostic services. Afr J Lab Med. 2017; 5(2):556. PMC: 5433831. DOI: 10.4102/ajlm.v5i2.556. View

5.
Urdea M, Penny L, Olmsted S, Giovanni M, Kaspar P, Shepherd A . Requirements for high impact diagnostics in the developing world. Nature. 2006; 444 Suppl 1:73-9. DOI: 10.1038/nature05448. View